HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
Castelao
A M
AM
Department of Nephrology, Ciutat Sanitaria de Bellvitge, Hospital Prínceps d'Espanya, University of Barcelona.
Griñó
J M
JM
Andrés
E
E
Gilvernet
S
S
Serón
D
D
Castiñeiras
M J
MJ
Roca
M
M
Galcerán
J M
JM
González
M T
MT
Alsina
J
J
D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001053:Apolipoproteins / Q000097:blood; D015992:Body Mass Index; D001835:Body Weight; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy*; D011507:Proteinuria; D019821:Simvastatin; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D001053:Apolipoproteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D008148:Lovastatin; D019821:Simvastatin